1 | copyright 2023 taylors tale | | | | | | | 1 | 0.43% |
2 | going on and keep | | | | | | | 1 | 0.43% |
3 | patient treated with gene | | | | | | | 1 | 0.43% |
4 | disease patient treated with | | | | | | | 1 | 0.43% |
5 | cln1 disease patient treated | | | | | | | 1 | 0.43% |
6 | a letter to my | | | | | | | 1 | 0.43% |
7 | purple flower in pavement | | | | | | | 1 | 0.43% |
8 | letter to my sister | | | | | | | 1 | 0.43% |
9 | to my sister on | | | | | | | 1 | 0.43% |
10 | my sister on national | | | | | | | 1 | 0.43% |
11 | to date read more | | | | | | | 1 | 0.43% |
12 | up to date read | | | | | | | 1 | 0.43% |
13 | keep up to date | | | | | | | 1 | 0.43% |
14 | and keep up to | | | | | | | 1 | 0.43% |
15 | on and keep up | | | | | | | 1 | 0.43% |
16 | whats going on and | | | | | | | 1 | 0.43% |
17 | with gene therapy started | | | | | | | 1 | 0.43% |
18 | about whats going on | | | | | | | 1 | 0.43% |
19 | learn about whats going | | | | | | | 1 | 0.43% |
20 | sister on national siblings | | | | | | | 1 | 0.43% |
21 | on national siblings day | | | | | | | 1 | 0.43% |
22 | continuing taylor’s powerful legacy | | | | | | | 1 | 0.43% |
23 | april 10 2019 0 | | | | | | | 1 | 0.43% |
24 | public policies we are | | | | | | | 1 | 0.43% |
25 | for lifechanging public policies | | | | | | | 1 | 0.43% |
26 | advocating for lifechanging public | | | | | | | 1 | 0.43% |
27 | and advocating for lifechanging | | | | | | | 1 | 0.43% |
28 | disease and advocating for | | | | | | | 1 | 0.43% |
29 | breakthrough treatments for batten | | | | | | | 1 | 0.43% |
30 | advancing breakthrough treatments for | | | | | | | 1 | 0.43% |
31 | by advancing breakthrough treatments | | | | | | | 1 | 0.43% |
32 | treated with gene therapy | | | | | | | 1 | 0.43% |
33 | gene therapy started by | | | | | | | 1 | 0.43% |
34 | rare diseases by advancing | | | | | | | 1 | 0.43% |
35 | the push to the | | | | | | | 1 | 0.43% |
36 | for patients and their | | | | | | | 1 | 0.43% |
37 | may 21 2020 1 | | | | | | | 1 | 0.43% |
38 | patients and their families | | | | | | | 1 | 0.43% |
39 | and their families cln1 | | | | | | | 1 | 0.43% |
40 | their families cln1 disease | | | | | | | 1 | 0.43% |